|
|
|
Volumn 10, Issue 1, 1997, Pages 54-57
|
|
Endothelins: New therapeutic opportunities
a
a
NONE
(United Kingdom)
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
2 [[2 [[2 [[(HEXAHYDRO 1H AZEPIN 1 YL)CARBONYL]AMINO] 4 METHYLPENTANOYL]AMINO] 3 (1 METHYL 1H INDOL 3 YL)PROPIONYL]AMINO] 3 (2 PYRIDYL)PROPIONIC ACID;
3 (2 CARBOXYMETHOXY 4 METHOXYPHENYL) 1 (3,4 METHYLENEDIOXYPHENYL) 5 PROPOXY 2 INDANCARBOXYLIC ACID;
4 (4 METHOXYPHENYL) 2 (3,4 METHYLENEDIOXYPHENYL) 4 OXO 3 (3,4,5 TRIMETHOXYBENZYL) 2 BUTENOIC ACID;
BOSENTAN;
CARVEDILOL;
CYCLO(DEXTRO TRYPTOPHYL DEXTRO ASPARTYLPROLYL DEXTRO VALYLLEUCYL);
ENDOTHELIN;
ENDOTHELIN 1;
ENDOTHELIN A RECEPTOR;
ENDOTHELIN A RECEPTOR ANTAGONIST;
ENDOTHELIN B RECEPTOR;
ENDOTHELIN B RECEPTOR ANTAGONIST;
ENDOTHELIN CONVERTING ENZYME;
ENDOTHELIN CONVERTING ENZYME INHIBITOR;
ENDOTHELIN RECEPTOR;
ENDOTHELIN RECEPTOR ANTAGONIST;
ENRASENTAN;
N (2,6 DIMETHYLPIPERIDINOCARBONYL) 4 METHYLLEUCYL DEXTRO (1 METHOXYCARBONYLTRYPTOPHANYL) DEXTRO NORLEUCINE;
PHOSPHORAMIDON;
SARAFOTOXIN S6C;
TAK 044;
UNCLASSIFIED DRUG;
CARDIOVASCULAR DISEASE;
CARDIOVASCULAR SYSTEM;
CONFERENCE PAPER;
DRUG RECEPTOR BINDING;
DRUG RESEARCH;
HUMAN;
MOLECULAR CLONING;
NONHUMAN;
PATHOPHYSIOLOGY;
PHYSIOLOGY;
|
|
EID: 0030984652
PISSN: 02140934
EISSN: None
Source Type: Journal
DOI: None Document Type: Conference Paper |
|
Times cited : (1)
|
|
References (0)
|
